249 related articles for article (PubMed ID: 37392933)
1. CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis.
Li R; Zhang J; Liu Q; Tang Q; Jia Q; Xiong Y; He J; Li Y
Acta Biomater; 2023 Sep; 168():484-496. PubMed ID: 37392933
[TBL] [Abstract][Full Text] [Related]
2. Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis.
Li Y; Zhang T; Zhang J; Liu Q; Jia Q; Chen W; Tang Q; Xiong Y; Xia Y; Xu Y; Mo L; Huang Y; He J
Biomaterials; 2023 Oct; 301():122232. PubMed ID: 37418856
[TBL] [Abstract][Full Text] [Related]
3. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of glycolysis in hepatic stellate cells and suppression of liver fibrogenesis with vitamin A-derivative decorated camptothecin micelles.
Xiang L; Wang X; Jiao Q; Shao Y; Luo R; Zhang J; Zheng X; Zhou S; Chen Y
Acta Biomater; 2023 Sep; 168():497-514. PubMed ID: 37507035
[TBL] [Abstract][Full Text] [Related]
5. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.
Wang X; Zhang W; Zeng S; Wang L; Wang B
Acta Biomater; 2024 Feb; 175():262-278. PubMed ID: 38141933
[TBL] [Abstract][Full Text] [Related]
6. Reactive Oxygen Species-Responsive Polypeptide Drug Delivery System Targeted Activated Hepatic Stellate Cells to Ameliorate Liver Fibrosis.
Hao Y; Song K; Tan X; Ren L; Guo X; Zhou C; Li H; Wen J; Meng Y; Lin M; Zhang Y; Huang H; Wang L; Zheng W
ACS Nano; 2022 Dec; 16(12):20739-20757. PubMed ID: 36454190
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of celastrol to renal interstitial myofibroblasts using fibronectin-binding liposomes attenuates renal fibrosis and reduces systemic toxicity.
Li R; Li Y; Zhang J; Liu Q; Wu T; Zhou J; Huang H; Tang Q; Huang C; Huang Y; Zhang Z; Zhang G; Zhao Y; Ma L; Feng Y; Mo L; Han M; He J
J Control Release; 2020 Apr; 320():32-44. PubMed ID: 31931051
[TBL] [Abstract][Full Text] [Related]
8. Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo.
Li Q; Ding Y; Guo X; Luo S; Zhuang H; Zhou J; Xu N; Yan Z
J Cell Mol Med; 2019 Mar; 23(3):1951-1962. PubMed ID: 30592139
[TBL] [Abstract][Full Text] [Related]
9. Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis.
Wang K; Chen H; Zheng J; Chen J; Chen Y; Yuan Y
J Control Release; 2024 Apr; 368():219-232. PubMed ID: 38367862
[TBL] [Abstract][Full Text] [Related]
10. Taurine attenuates activation of hepatic stellate cells by inhibiting autophagy and inducing ferroptosis.
Li S; Ren QJ; Xie CH; Cui Y; Xu LT; Wang YD; Li S; Liang XQ; Wen B; Liang MK; Zhao XF
World J Gastroenterol; 2024 Apr; 30(15):2143-2154. PubMed ID: 38681990
[TBL] [Abstract][Full Text] [Related]
11. Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development.
Sung YC; Liu YC; Chao PH; Chang CC; Jin PR; Lin TT; Lin JA; Cheng HT; Wang J; Lai CP; Chen LH; Wu AY; Ho TL; Chiang T; Gao DY; Duda DG; Chen Y
Theranostics; 2018; 8(4):894-905. PubMed ID: 29463989
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway.
Yuan S; Wei C; Liu G; Zhang L; Li J; Li L; Cai S; Fang L
Cell Prolif; 2022 Jan; 55(1):e13158. PubMed ID: 34811833
[TBL] [Abstract][Full Text] [Related]
13. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
[TBL] [Abstract][Full Text] [Related]
14. PDGFRβ-targeted TRAIL specifically induces apoptosis of activated hepatic stellate cells and ameliorates liver fibrosis.
Li R; Li Z; Feng Y; Yang H; Shi Q; Tao Z; Cheng J; Lu X
Apoptosis; 2020 Feb; 25(1-2):105-119. PubMed ID: 31894448
[TBL] [Abstract][Full Text] [Related]
15. Hepatic stellate cells specific liposomes with the Toll-like receptor 4 shRNA attenuates liver fibrosis.
Zhang Y; Li Y; Mu T; Tong N; Cheng P
J Cell Mol Med; 2021 Jan; 25(2):1299-1313. PubMed ID: 33336563
[TBL] [Abstract][Full Text] [Related]
16. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
[TBL] [Abstract][Full Text] [Related]
17. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
18. An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis.
Li Y; Pu S; Liu Q; Li R; Zhang J; Wu T; Chen L; Li H; Yang X; Zou M; Xiao J; Xie W; He J
J Control Release; 2019 Jun; 303():77-90. PubMed ID: 31004666
[TBL] [Abstract][Full Text] [Related]
19. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis.
El-Mezayen NS; El-Hadidy WF; El-Refaie WM; Shalaby TI; Khattab MM; El-Khatib AS
J Control Release; 2017 Nov; 266():226-237. PubMed ID: 28965860
[TBL] [Abstract][Full Text] [Related]
20. Albumin self-modified liposomes for hepatic fibrosis therapy via SPARC-dependent pathways.
Wang J; Ding Y; Zhou W
Int J Pharm; 2020 Jan; 574():118940. PubMed ID: 31830578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
